ondersteun onze principezaak tegen @AbbVie over de €1,2 miljard overwinst op #humira met uw steunbetuiging op onze… https://t.co/WI8R2Px5no

#crohnsdisease It’s not just pooping lots. IT’

#crohnsdisease It’s not just pooping lots.

IT’s medications with many side effects

IT’s hospital appointments c… https://t.co/w6m8GFhUZS

The first biosimilar to Humira is now available in

The first biosimilar to Humira is now available in the U.S., Amgen announced. https://t.co/a1CCLONUV5… https://t.co/uj6g1EaIU5

Headed to Sacramento to speak with policy makers
Aren’t you tired of being sick and tired
being told it’s “crohns”… https://t.co/wkBjcPOrqw

The future of #BIOSIMILARS in @IBD 🤔

⤴️next lessons within #IBDscop⤵️

Useful information and tips from @IBDMD 👌 https://t.co/SNgLvK8dY0

Humira-sized blockbusters may become harder to achieve, though, which will change how drugmakers develop and commer… https://t.co/PDZavH9d1Z

Always looking for speakers interested in #medicationsafety, #drugshortages, and #biosimilars, to speak at the… https://t.co/yK6bxjW6jS

New @cardinalhealth $CAH report has loads of neat data on #physician #biosimilar views